123
Participants
Start Date
April 7, 2017
Primary Completion Date
April 7, 2021
Study Completion Date
April 7, 2021
Pirfenidone
Pirfenidone three times daily (2403 mg) for 52 weeks
Placebo
Placebo three times daily for 52 weeks
The Prince Charles Hospital, Camperdown
Melbourne Alfred Hospital, Melbourne
Royal Brompton, Brisbane
Weill Cornell Medicine, New York
John Hopkins Medicine, Baltimore
University of Miami, Miami
University of Alabama Site at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
University of Michigan, Ann Arbor
Mayo Clinic, Rochester
Tulane Medical Center, New Orleans
National Jewish Health, Denver
University of Utah Health Care, Salt Lake City
University of California San Francisco, San Francisco
University of Washington, Seattle
Brigham and Women's Hospital, Boston
Royal Prince Alfred Hospital, Camperdown
University of Calgary Cummings School of Medicine, Calgary
St. Paul's Hospital - Providence Health Care, Vancouver
St. Joseph's Healthcare, Hamilton
Toronto General Hospital, Toronto
North Bristol NHS Trust Headquarters, Southmead Hospital, Bristol
Papworth Hospital NHS Foundation Trust, Cambridge
Royal Devon and Exeter NHS Foundation, Exeter
Leeds Teaching Hospitals NHS Trust, Leeds
University Hospitals of Leicester NHS Foundation Trust, Leicester
Aintree University Hospitals NHS Foundation Trust, Liverpool
Royal Brompton and Harefield NHS Foundation Trust, London
Manchester University NHS Foundation Trust (South) Wythenshawe Hospita, Manchester
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich
Oxford University Hospitals NHS Foundation Trust, Oxford
University Hospital Southampton NHS Foundation Trust, Southhampton
Brigham and Women's Hospital
OTHER